Wednesday, January 25, 2006

Inhaled cyclosporine may stave off long-term rejection and improve survival

As a lung transplant patient anything that offers hope for the prevention of long-term rejection and improves survival is something that catches my attention. As the investigators state, more studies are needed but these results should be received enthusiastically.

From Transplant Living
January 12, 2006

NEW YORK (Reuters Health) - Use of inhaled cyclosporine, in addition to other immune-suppressing drugs in pill form, does not help prevent the early rejection of lung transplants, but it does seem to stave off long-term rejection and improve survival, according to a report in The New England Journal of Medicine.

Conventional immunosuppressive drugs do not prevent long-term rejection after lung transplantation, lead author Dr. Aldo T. Iacono, from the University of Maryland in Baltimore, and colleagues note. Delivery of cyclosporine directly to the lung transplant, through the use of an inhaler, may help cut the rates of both early and long-term rejection.
Full news article

No comments: